Wed, August 25, 2021
Tue, August 24, 2021
Mon, August 23, 2021

Marc Frahm Downgraded (TBPH) to Hold and Decreased Target to $14 on, Aug 24th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-14-on-aug-24th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Marc Frahm of Cowen & Co., Downgraded "Theravance Biopharma, Inc." (TBPH) to Hold and Decreased Target from $42 to $14 on, Aug 24th, 2021.

Marc has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Marc's Rating of Hold.



This is the rating of the analyst that currently disagrees with Marc


  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $27 on, Friday, July 16th, 2021